142 related articles for article (PubMed ID: 16753304)
1. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.
Lu L; Neff F; Fischer DA; Henze C; Hirsch EC; Oertel WH; Schlegel J; Hartmann A
Neurobiol Dis; 2006 Aug; 23(2):409-21. PubMed ID: 16753304
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease.
Lu L; Neff F; Alvarez-Fischer D; Henze C; Xie Y; Oertel WH; Schlegel J; Hartmann A
Exp Neurol; 2005 Sep; 195(1):27-39. PubMed ID: 15944136
[TBL] [Abstract][Full Text] [Related]
3. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
[TBL] [Abstract][Full Text] [Related]
4. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?
Le Pen G; Sonnier L; Hartmann A; Bizot JC; Trovero F; Krebs MO; Prochiantz A
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S107-11. PubMed ID: 18585951
[TBL] [Abstract][Full Text] [Related]
5. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.
Liang CL; Wang TT; Luby-Phelps K; German DC
Exp Neurol; 2007 Feb; 203(2):370-80. PubMed ID: 17010972
[TBL] [Abstract][Full Text] [Related]
7. Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.
McRitchie DA; Cartwright HR; Halliday GM
Exp Neurol; 1997 Mar; 144(1):202-13. PubMed ID: 9126172
[TBL] [Abstract][Full Text] [Related]
8. Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: mesencephalic dopaminergic neurons.
Counihan TJ; Landwehrmeyer GB; Standaert DG; Kosinski CM; Scherzer CR; Daggett LP; Veliçelebi G; Young AB; Penney JB
J Comp Neurol; 1998 Jan; 390(1):91-101. PubMed ID: 9456178
[TBL] [Abstract][Full Text] [Related]
9. The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system.
Vernier P; Moret F; Callier S; Snapyan M; Wersinger C; Sidhu A
Ann N Y Acad Sci; 2004 Dec; 1035():231-49. PubMed ID: 15681811
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic neurons.
Chinta SJ; Andersen JK
Int J Biochem Cell Biol; 2005 May; 37(5):942-6. PubMed ID: 15743669
[TBL] [Abstract][Full Text] [Related]
11. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization.
German DC; Manaye K; Smith WK; Woodward DJ; Saper CB
Ann Neurol; 1989 Oct; 26(4):507-14. PubMed ID: 2817827
[TBL] [Abstract][Full Text] [Related]
12. Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta.
Thuret S; Bhatt L; O'Leary DD; Simon HH
Mol Cell Neurosci; 2004 Mar; 25(3):394-405. PubMed ID: 15033168
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism.
Greene JG; Dingledine R; Greenamyre JT
Neurobiol Dis; 2005 Feb; 18(1):19-31. PubMed ID: 15649693
[TBL] [Abstract][Full Text] [Related]
14. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel genes regulated in the developing human ventral mesencephalon.
Jørgensen JR; Juliusson B; Henriksen KF; Hansen C; Knudsen S; Petersen TN; Blom N; Seiger A; Wahlberg LU
Exp Neurol; 2006 Apr; 198(2):427-37. PubMed ID: 16473350
[TBL] [Abstract][Full Text] [Related]
16. Cell-Specific RNA Quantification in Human SN DA Neurons from Heterogeneous Post-mortem Midbrain Samples by UV-Laser Microdissection and RT-qPCR.
Duda J; Fauler M; Gründemann J; Liss B
Methods Mol Biol; 2018; 1723():335-360. PubMed ID: 29344870
[TBL] [Abstract][Full Text] [Related]
17. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
Maingay M; Romero-Ramos M; Carta M; Kirik D
Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
[TBL] [Abstract][Full Text] [Related]
18. Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease.
Noelker C; Schwake M; Balzer-Geldsetzer M; Bacher M; Popp J; Schlegel J; Eggert K; Oertel WH; Klockgether T; Dodel RC
Neurosci Lett; 2012 Jan; 507(1):10-5. PubMed ID: 22155091
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.
Nagel F; Bähr M; Dietz GP
Brain Res Bull; 2009 Jun; 79(5):303-9. PubMed ID: 19406215
[TBL] [Abstract][Full Text] [Related]
20. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics.
Bogerts B; Häntsch J; Herzer M
Biol Psychiatry; 1983 Sep; 18(9):951-69. PubMed ID: 6640008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
